Skip to main content

Ginkgo Bioworks Holdings, Inc.

DNA
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001830214

In the last 90 days, Ginkgo Bioworks Holdings, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $359.2M in total; Viking Global Investors is the only superinvestor holding it.

Q3 2025 vs. Q2 2025

How the institutions holding Ginkgo Bioworks Holdings, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of DNA: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders1662174+10
Shares33.3M16230.2M−3.16M (−9.5%)
Value$375.0M$1.82K$437.0M+$61.9M (+16.5%)

2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Ginkgo Bioworks Holdings, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to DNA in Q3 2025
InstitutionSharesValue% of portfolio
Allianz Asset Management GmbH192,160$2.80M0.00%
Caxton Associates LLP129,588$1.89M0.05%
Susquehanna Portfolio Strategies, LLC108,982$1.59M0.03%
SPX Equities Gestao de Recursos Ltda100,000$1.46M0.12%
Balyasny Asset Management LLC97,918$1.43M0.00%
Jane Street Group, LLC85,019$1.24M0.00%
Jacobs Levy Equity Management, Inc70,867$1.03M0.00%
CWM Advisors, LLC31,577$460.4K0.04%
Massachusetts Financial Services Co30,268$441.3K0.00%
Simplex Trading, LLC23,533$343.0K0.01%
Russell Investments Group, Ltd.21,415$312.2K0.00%
Boston Standard Wealth Management, LLC15,165$221.0K0.04%
Caption Management, LLC15,000$218.7K0.01%
Numerai GP LLC13,204$192.5K0.03%
PharVision Advisers, LLC13,177$192.1K0.11%
Rockefeller Capital Management L.P.11,047$161.1K0.00%
Acadian Asset Management LLC6,527$94.0K0.00%
Group One Trading, L.P.6,084$88.7K0.00%
State of Wyoming5,067$73.9K0.01%
STRS Ohio3,000$43.7K0.00%
Quarry LP1,963$28.6K0.01%
Quent Capital, LLC1,009$14.7K0.00%
Strategic Advocates LLC482$7.03K0.00%
Quadrant Capital Group LLC448$6.53K0.00%
Financial Consulate, Inc250$3.65K0.00%
Sofos Investments, Inc.100$1.46K0.00%
SRS Capital Advisors, Inc.95$1.39K0.00%
GAMMA Investing LLC88$1.28K0.00%
Advisory Services Network, LLC58$8460.00%
Nisa Investment Advisors, LLC36$5250.00%
Sunbelt Securities, Inc.35$5100.00%

Sold out (21)

Institutions that held Ginkgo Bioworks Holdings, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Not filed for Q3 2025 yet (2)

Institutions that held Ginkgo Bioworks Holdings, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DNA in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Legacy Investment Solutions, LLC112$1.26K
Parkworth Wealth Management, Inc.50$563